According to Zacks.com, “Medtronic recently launched its OsteoCool radiofrequency (RF) Ablation System in the U.S. market, subsequent to the receipt of the FDA 510(k) approval for the same. The OsteoCool System is designed to treat cancer patients suffering from painful spinal metastasis.” For more information, please visit: http://www.zacks.com/stock/news/204112/medtronic-launches-osteocool-system-for-spinal-metastasis